A novel approach to treatment with high-dose steroid as a differentiation inducer in children with acute myeloblastic leukemia

Pediatric Pathology and Molecular Medicine

Volumn 19, Issue 4, 2000, Pages 251-259

  Hicsonmez, G ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Acute myeloblastic leukemia; Apoptosis; CD34+ cells; Children; Differentiation; High dose methylprednisolone

Indexed keywords

CD34 ANTIGEN; CYTARABINE; METHYLPREDNISOLONE; MITOXANTRONE; RETINOIC ACID;

ACUTE MYELOBLASTIC LEUKEMIA; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BRADYCARDIA; CANCER CELL; CANCER CHEMOTHERAPY; CANCER INFILTRATION; CELL DIFFERENTIATION; CELL MATURATION; CHILD; CUSHINGOID SYNDROME; DOSE RESPONSE; DRUG WITHDRAWAL; FEMALE; GRANULOCYTE; HUMAN; HUMAN CELL; HYPERGLYCEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; NEUTROPENIA; PRIORITY JOURNAL; PROGNOSIS; REMISSION; STEM CELL; STEROID THERAPY; TREATMENT OUTCOME;

EID: 0033785048     PISSN: 15227952     EISSN: None     Source Type: Journal    
DOI: 10.1080/pdp.19.4.251.259     Document Type: Article

References (60)

1. In vitro induction of granulocyte differentiation in hematopoietic cells from leukemic and nonleukemic patients
2. Control of normal cell differentiation and phenotypic reversion of malignancy in myeloid leukemia
3. Differentiation of myeloid leukemia cells: New possibilities for therapy
4. Differentiation therapy of leukemia: Achievements, limitations and future prospects
5. Induction of differentiation of the human acute myelogenous leukemia cells; therapeutic implications
6. Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia
7. All-trans-retinoic acid as a differentiating agent in the treatment of acute promyelocytic leukemia
8. Acute promyelocytic leukemia: Biology and treatment
9. Induction of specific changes in the surface membrane of myeloid leukemic cells by steroid hormones
10. Glucocorticoid induced differentiation of cultured mouse myeloid leukemic cells
11. Steroid hormone receptors and the differentiation of myeloid leukemic cells
12. Control of proliferating potential of myeloid leukemia cells during long term treatment with vitamin D3 analoques and other differentiation inducers in combination with anti-leukemic drugs. In vitro and in vivo studies
13. Prolongation of survival time of mice inoculated with myeloid leukemia cells by inducers of normal differentiation
14. Glucorticoid-stimulated increase in chemotactic peptide receptors on differentiating human myeloid leukemia (HL-60) cells
15. A combination of a T cell-derived lymphokine differentiation-inducing activity and physiologic concentration of retinoic acid induces HL 60 to differentiate to cells with functional chemotactic peptide receptors
16. Dexamethasone does not counteract the response of acute promyelocytic leukemia cells to all-trans retinoic acid
17. Differentiation of myeloid leukemic cells induced by high-dose methylprednisolone in patients with acute myeloblastic leukemia and its therapeutic potential
18. Massive prednisone and prednisolone therapy in leukemia and lymphomas in the adult
19. Effect of massive prednisone and prednisolone therapy in leukemia and lymphoma
20. Treatment of acute leukemia in adults with massive doses of prednisone and prednisolone
21. Critical evaluation of massive steroid therapy of acute leukemia
22. Varying prednisone dosage in remission induction of previously untreated childhood leukemia
23. High-dose methylprednisolone for remission induction in children with acute nonlymphoblastic leukemia
24. The potential role of high-dose methylprednisolone on the maturation of leukemic cells in children with acute promyelocytic leukemia (APL)
25. Direct morphological evidence of high-dose methylprednisolone induced maturation of leukemic cells in children with acute nonlymphoblastic leukemia
26. Differentiation of leukemic cells induced by short-course high-dose methylprednisolone in children with different subtypes of acute myeloblastic leukemia
27. Morphologic evidence of in vivo differentiation in acute myeloblastic leukemia
28. Control of programmed cell death in normal and leukemic cells: New implications for therapy
29. Apoptosis and disease
30. Morphologic evidence of apoptosis in childhood acute myeloblastic leukemia treated with high-dose methylprednisolone
31. Effects of methylprednisolone on human myeloid leukemic cells in vitro
32. Glucocorticoids induce apoptosis in acute myeloid leukemia cell lines with a t(8;21) chromosome translocation
33. High-risk subgroup of acute myelomonocytic leukemia (AMML) with orbito-ocular granulocytic sarcoma (OOGS) in Turkish children. Retrospective analysis of clinical, hematological, ultrastructural and therapeutical findings of thirty-three OOGS
34. Poor prognosis in children with acute nonlymphoblastic leukemia in Turkey
35. Dramatic effect of high-dose methylprednisolone on orbital granulocytic sarcoma
36. High remission rate in acute myeloblastic leukemia in children treated with high-dose methylprednisolone
37. Dramatic resolution of pleural effusion in children with chronic myelomonocytic leukemia following short-course high-dose methylprednisolone
38. Complete remission in acute myeloid leukemia after treatment with recombinant human granulocyte-colony stimulating factor and high dose intravenous methylprednisolone
39. Fundamentals of chemo-differentiation therapy of myeloid leukemia
40. Differentiation induction in myelodysplasia and acute myeloid leukemia: Use of synergestic drug combinations
41. Acute promyelocytic leukemia: Biology and treatment
42. High-dose methylprednisolone for children with acute lymphoblastic leukemia and unfavorable presenting features
43. A comparison of the effect of high-dose methylprednisolone with conventional-dose predniosolone in acute lymphoblastic leukemia patient with randomization
44. High-dose methylprednisolone, low-dose cytosine arabinoside and mitoxantrone in children with myelodysplastic syndromes
45. High-dose intravenous glucocorticoid in the treatment of childhood acquired aplastic anemia
46. High-dose intravenous corticosteroid treatment in childhood idiopathic myelo-fibrosis
47. Acceleration of leukocyte recovery by administration of short-course high-dose methylprednisolone in children with acute lymphoblastic leukemia
48. The effect of short-course high-dose corticosteroid therapy on peripheral blood CD34 positive progenitor cells in children with acute leukemia
49. High-dose methylprednisolone in resistant and relapsed children with acute lymphoblastic leukemia
50. High-dose methylprednisolone for remission induction in hypoplastic acute myeloid leukemia
51. Protection of murine bone marrow by dexamethasone during cytotoxic chemotherapy
52. The effect of high-dose methylprednisolone combined chemotherapy on CD 34 positive cells in acute lymphoblastic leukemia
53. The effect of high-dose methylprednisolone treatment on GM-CSF level in children with acute leukemia: A pilot study
54. Serum TNF-alpha, gamma-INF, G-CSF and GM-GSF levels in neutropenic children with acute leukemia treated with short-course high-dose methylprednisolone
55. High-dose intravenous corticosteroid treatment for patients with Diamond-Blackfan syndrome resistant or refractory to conventinal treatment
56. High-dose intravenous methylprednisolone therapy for patients with Diamond-Blackfan anemia refractory to conventional doses of prednisone
57. Pulse metylprednisolone therapy for acute childhood idiopathic purpura
58. High dose methylprednisolone in refractory chronic lymphocytic leukemia Leuk Lymph
59. High-dose intravenous methylprednisolone in myasthenia gravis
60. High intravenous doses of methylprednisolone for acute cadaveric renal allograft rejection